Reed's Seeks NYSE American Listing, Launches Functional Soda Line

TL;DR

**REED's S-1 filing for a NYSE American listing and new functional soda line is a high-stakes gamble to revitalize the brand, but the reverse stock split and uncertain listing approval make it a speculative play.**

AI Summary

REED'S, INC. (REED) is offering 1,326,260 shares of common stock, with an option for underwriters to purchase an additional 198,939 shares, following a 1-for-6 reverse stock split effected on October 31, 2025. The company's common stock currently trades on the OTCQX Best Market at $7.54 per share as of November 11, 2025, and it has applied to list on the NYSE American under the same symbol. REED operates an asset-light model, utilizing seven independent co-packers and five distribution centers to produce and distribute its 50 products across the U.S. and internationally. The company launched a new multi-functional soda line in April 2025, formulated with organic ginger, adaptogen mushroom extracts, and prebiotic fiber, securing approximately 9,000 points of distribution. This strategic move targets the growing $2.1 billion ginger ale segment, which grew 9% in 2024, and the broader $45 billion U.S. carbonated soft drink market, focusing on natural, lower-sugar, and functional beverages. Key risks include the uncertainty of NYSE American listing approval and the inherent risks of being a 'smaller reporting company' and potentially a 'controlled company'.

Why It Matters

This S-1 filing signals REED's ambition to elevate its market presence by moving from the OTCQX to the NYSE American, potentially increasing liquidity and investor visibility. For investors, the offering of 1,326,260 shares, coupled with the recent 1-for-6 reverse stock split, aims to improve share price and meet listing requirements, but also dilutes existing shareholders. The launch of a new multi-functional soda line positions REED to capitalize on the booming health and wellness beverage trend, intensifying competition with established players in the $45 billion U.S. CSD market. Employees and customers could see benefits from increased brand recognition and expanded product availability if the NYSE American listing is approved and the new product line gains traction.

Risk Assessment

Risk Level: high — The risk level is high due to several factors. The company recently effected a 1-for-6 reverse stock split on October 31, 2025, often a sign of a struggling stock price. Furthermore, the application to list on the NYSE American is not yet approved, and there is "no assurance that such application will be approved," which is a condition to this offering. The company also identifies as a "smaller reporting company" and potentially a "controlled company," which may lead to reduced reporting requirements and corporate governance standards, increasing investor risk.

Analyst Insight

Investors should approach REED with caution, recognizing the speculative nature of this offering. Monitor the NYSE American listing approval closely, as it's a critical condition for the offering. Evaluate the market reception and sales performance of the new multi-functional soda line to gauge its potential impact on future revenue and profitability.

Key Numbers

• 1,326,260 — Shares of common stock offered (Primary offering amount in the S-1 filing)
• 1-for-6 — Reverse stock split ratio (Effected on October 31, 2025, to adjust share price and meet listing requirements)
• $7.54 — Last reported sale price per share (On OTCQX Best Market as of November 11, 2025)
• 198,939 — Additional shares for underwriters' option (Option for 45 days from prospectus date)
• $805,000 — Total underwriting discounts and commissions (If underwriters exercise option in full)
• $10,695,000 — Total proceeds before expenses (If underwriters exercise option in full)
• $45 billion — U.S. carbonated soft drink market size (Overall market REED competes within)
• $2.1 billion — Ginger ale segment market size (Grew approximately 9% in 2024, a key focus for REED)
• 9,000 — Points of distribution (Secured for the new multi-functional soda line launched in April 2025)
• 7% — ABV of Reed's Zero Sugar Classic Mule (Alcohol by volume for their alcoholic offering)

Key Players & Entities

• REED'S, INC. (company) — Registrant and issuer of common stock
• Cyril A. Wallace, Jr. (person) — Chief Executive Officer and Agent for Service
• Cooley LLP (company) — Legal counsel for the offering
• Thompson Hine LLP (company) — Legal counsel for the offering
• A.G.P. (company) — Sole Book-Running Manager for the offering
• Roberts & Ryan (company) — Co-Manager for the offering
• Securities and Exchange Commission (regulator) — Regulatory body for the S-1 filing
• NYSE American, LLC (company) — Targeted stock exchange for listing
• OTCQX Best Market (company) — Current trading market for REED's common stock
• Delaware (regulator) — State of incorporation for REED'S, INC.

FAQ

Risk Factors

• NYSE American Listing Approval [high — regulatory]: The company's application to list on the NYSE American is subject to approval. Failure to meet listing requirements could prevent the company from accessing capital markets through this venue, impacting its growth strategy and investor liquidity.
• Smaller Reporting Company Status [medium — financial]: As a smaller reporting company, REED's disclosure requirements are less stringent, which may limit the information available to investors for thorough analysis. This status can also affect investor perception and access to capital.
• Controlled Company Status [medium — financial]: The company may be considered a 'controlled company' under NYSE American rules, meaning it could be exempt from certain corporate governance requirements. This could concentrate voting power and potentially limit independent oversight.
• Reliance on Co-Packers and Distributors [medium — operational]: REED operates an asset-light model relying on seven independent co-packers and five distribution centers. Disruptions at any of these facilities, or issues with co-packer quality or capacity, could significantly impact production and delivery of its 50 products.
• Competition in CSD Market [high — market]: The company competes in the $45 billion U.S. carbonated soft drink market, which is dominated by large, established players. Gaining and maintaining market share against these competitors, especially in the growing $2.1 billion ginger ale segment, presents a significant challenge.
• New Product Launch Execution [medium — operational]: The success of the new multi-functional soda line, launched in April 2025 and secured in approximately 9,000 points of distribution, is critical. Failure to gain traction or meet consumer demand for this product could negatively impact revenue and growth prospects.

Industry Context

REED's, Inc. operates within the expansive U.S. carbonated soft drink (CSD) market, valued at $45 billion. The company is strategically targeting the $2.1 billion ginger ale segment, which demonstrated robust growth of 9% in 2024. Key industry trends favor natural, lower-sugar, and functional beverages, a niche REED aims to capture with its new multi-functional soda line.

Regulatory Implications

The company's application for listing on the NYSE American is a significant regulatory hurdle. Approval is contingent on meeting specific listing standards. Furthermore, its status as a 'smaller reporting company' and potential 'controlled company' may affect governance requirements and investor scrutiny.

What Investors Should Do

1. Monitor NYSE American Listing Approval
2. Evaluate New Product Line Performance
3. Assess Reliance on Third-Party Partners
4. Analyze Competitive Positioning

Key Dates

• 2025-10-31: Reverse stock split effected — A 1-for-6 reverse stock split was implemented, likely to increase the per-share price to meet exchange listing requirements and improve marketability.
• 2025-04-01: New multi-functional soda line launched — Introduction of a new product line targeting functional beverage trends, aiming to capture market share in the growing ginger ale segment.
• 2025-11-11: Last reported sale price on OTCQX — The stock traded at $7.54 per share, providing a current market valuation reference point before the potential NYSE American listing.

Glossary

Reverse Stock Split

A corporate action where a company reduces the total number of its outstanding shares by consolidating existing shares into fewer, proportionally more valuable shares. (Effected by REED's, Inc. on October 31, 2025, at a 1-for-6 ratio, likely to increase the share price to meet NYSE American listing requirements.)

Smaller Reporting Company

A classification by the SEC for companies meeting certain revenue and public float thresholds, allowing for reduced financial disclosure requirements. (REED's, Inc. is identified as a smaller reporting company, which may impact the depth of information available to investors.)

Controlled Company

A company where more than 50% of the voting power is held by an individual, group, or another company, potentially exempting it from certain NYSE corporate governance rules. (REED's, Inc. may be considered a controlled company, which could have implications for corporate governance and board independence.)

Asset-Light Model

A business strategy where a company minimizes its ownership of physical assets, often outsourcing production and logistics to third parties. (REED's, Inc. utilizes an asset-light model with co-packers and distributors, reducing capital expenditure but increasing reliance on external partners.)

Points of Distribution

The number of retail locations or channels where a company's products are available for sale. (REED's new soda line secured approximately 9,000 points of distribution, indicating initial market access and sales potential.)

Underwriters' Option

A provision in an underwriting agreement that allows the underwriters to purchase additional shares from the issuer at the offering price within a specified period. (Allows underwriters to purchase an additional 198,939 shares, potentially increasing the total offering size and proceeds for REED's, Inc.)

Year-Over-Year Comparison

Information comparing key metrics to a previous filing is not available in the provided context. The S-1 filing details the current offering and company status post-reverse stock split, but does not offer historical comparative data for revenue, margins, or risk factors relative to a prior period's filing.

Key Financial Figures

• $7.54 — mmon stock on the OTCQX Best Market was $7.54 per share. We have applied to list our
• $805,000 — s and commissions payable by us will be $805,000 and the total proceeds to us, before ex
• $10,695,000 — roceeds to us, before expenses, will be $10,695,000. Sole Book-Running Manager A.G.P.
• $45 billion — ts. We compete within the approximately $45 billion U.S. carbonated soft drink (“CSD&
• $2.1 billion — nt increasing approximately 9% to reach $2.1 billion. Functional and “modern soda&rdqu

Filing Documents

• forms-1.htm (S-1) — 1027KB
• ex1-1.htm (EX-1.1) — 264KB
• ex3-5.htm (EX-3.5) — 216KB
• ex4-6.htm (EX-4.6) — 2KB
• ex5-1.htm (EX-5.1) — 12KB
• ex23-1.htm (EX-23.1) — 3KB
• ex107.htm (EX-FILING FEES) — 20KB
• forms-1_001.jpg (GRAPHIC) — 39KB
• ex4-6_001.jpg (GRAPHIC) — 1754KB
• ex4-6_002.jpg (GRAPHIC) — 598KB
• ex5-1_001.jpg (GRAPHIC) — 3KB
• 0001493152-25-021613.txt ( ) — 4956KB
• ex107_htm.xml (XML) — 4KB

Underwriting

Underwriting Discounts and Commissions (1) $ $ Proceeds, Before Expenses, to Reed’s, Inc. $ $ (1) See the section titled “Underwriting” for additional information regarding underwriting compensation. The underwriters are offering the shares on a firm commitment basis. Delivery of the shares of common stock is expected to be made on or about , 2025. We have granted the underwriters an option for a period of 45 days from the date of this prospectus to purchase up to an additional 198,939 shares of common stock. If the underwriters exercise the option in full, the total underwriting discounts and commissions payable by us will be $805,000 and the total proceeds to us, before expenses, will be $10,695,000. Sole Book-Running Manager A.G.P. Co-Manager Roberts & Ryan Prospectus dated , 2025 TABLE OF CONTENTS P age PROSPECTUS SUMMARY 1 THE OFFERING 9 SUMMARY CONSOLIDATED FINANCIAL INFORMATION 10

RISK FACTORS

RISK FACTORS 12 SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS 32 MARKET AND INDUSTRY DATA 34

USE OF PROCEEDS

USE OF PROCEEDS 35 DIVIDEND POLICY 36 CAPITALIZATION 37

DILUTION

DILUTION 39 PRINCIPAL STOCKHOLDERS 41

DESCRIPTION OF CAPITAL STOCK

DESCRIPTION OF CAPITAL STOCK 42 CERTAIN MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO NON-U.S. HOLDERS 47

UNDERWRITING

UNDERWRITING 51 LEGAL MATTERS 55 EXPERTS 55 WHERE YOU CAN FIND ADDITIONAL INFORMATION 55 INCORPORATION OF CERTAIN INFORMATION BY REFERENCE 56 We have not, and the underwriters have not, authorized anyone to provide you with information other than in this prospectus or in any free writing prospectus we may authorize to be delivered or made available to you. We take no responsibility for and cannot provide any assurance as to the reliability of any other information others may give you. We are not, and the underwriters are not, making an offer to sell shares of our common stock in any jurisdiction where the offer or sale is not permitted. The information in this prospectus or any free writing prospectus is accurate only as of its date, regardless of its time of delivery or of any sale of shares of our common stock. Our business, financial condition, results of operations, and prospects may have changed since that date. For investors outside the United States: We have not, and the underwriters have not, done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside of the United States. i PROSPECTUS SUMMARY This summary highlights selected information contained in greater detail elsewhere in this prospectus. This summary is not complete and does not contain all of the information you should consider in making your investment decision. Before investing in our common stock, you should carefully read this entire prospectus, including the information incorporated by reference herein. You should carefully consider, among other things, the section titled “Risk Factors”

View Full Filing

View this S-1 filing on SEC EDGAR